Outcome of Board Meeting

Emphasis Of MatterPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹1.50

prior close

₹1.53

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+1.7% vs market

Trading - Chemicals peers, median of 10sector-0.7%+2.7% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.7 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0+0.3+1.7-0.7+2.7

Next day

+1.3-1.1+2.5-0.2+1.5

+0.7-1.3+2.0-1.9+2.5

+1.3-1.1+2.5-2.4+3.8

+0.7-2.4+3.1-3.4+4.1

+0.7-2.2+2.9-5.0+5.6

-0.7-3.0+2.4-3.3+2.6

15d

-2.0-7.5+5.5-3.7+1.7

-44.0-7.4-36.6-11.6-32.4

-51.3+1.9-53.2-2.7-48.6

-13.3+3.6-16.9-1.0-12.3

UpDownMarket · Nifty Microcap 250Sector · Trading - Chemicals peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Evexia Lifecare's board approved unaudited financial results for Q3 and 9M FY26 ended Dec 31, 2025. Standalone revenue from operations rose to ₹2,459.92 lakhs in Q3 (vs ₹2,157.97 lakhs YoY) and ₹7,028.54 lakhs for 9M (vs ₹6,870.76 lakhs YoY). Standalone Q3 PAT doubled to ₹40.73 lakhs (vs ₹19.23 lakhs YoY), with 9M PAT at ₹131.58 lakhs (vs ₹117.80 lakhs). On a consolidated basis, Q3 revenue was ₹2,524.38 lakhs and 9M revenue ₹7,306.39 lakhs, with Q3 PAT of ₹29.19 lakhs and 9M PAT of ₹130.28 lakhs. The statutory auditor issued an unmodified limited review conclusion for both standalone and consolidated results, though the consolidated report carries an Emphasis of Matter noting that subsidiary financials were consolidated based on unaudited statements.

Likely market impact

Marginal revenue growth but strong quarterly profit improvement signals better operational efficiency. The Emphasis of Matter on unaudited subsidiary numbers is a mild governance flag for retail investors tracking the consolidated picture.